News China30 Aug 2019

Listed company plans merger with Guohua Life

| 30 Aug 2019

Shenzhen listed Hubei Biocause Pharmaceutical has announced that it plans to merge with Guohua Life with the merged entity to adopt the insurer's name.

eWeekly China Newsletter is available to eChina subscribers only.

Please login to read the full news

Please Click here to subscribe eChina.

Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.

 
Error : Object reference not set to an instance of an object.

Recent Comments

Other News


Follow Asia Insurance Review